SCHEMBL2955719

SCHEMBL2955719

Cc1nc(N2CCN(S(C)(=O)=O)CC2)ccc1-n1cnc2c(N)nc(N)nc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.37
CDK1 P06493 2/20 0.35
CCNB1 P14635 2/20 0.35
CCNE1 P24864 2/20 0.35
CDK2 P24941 2/20 0.35
ALDH1A1 P00352 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 1/20 0.33
DPP4 P27487 1/20 0.33
DHFR P00374 2/20 0.33
HRH4 Q9H3N8 1/20 0.33
SMO Q99835 1/20 0.32
PI4KA P42356 1/20 0.32
PI4K2B Q8TCG2 1/20 0.32
PI4K2A Q9BTU6 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
ATR Q13535 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2952277 0.77 MAP4K4 (0.45) CDK1CCNB1CCNE1CDK2ATR
SCHEMBL2956345 0.71 PDE4B (0.42) CDK1CDK2PI4KB
SCHEMBL2953676 0.69 EGFR (0.39) DHFRHRH4
SCHEMBL2951209 0.68 KDM4E (0.42) CDK1CCNB1CCNE1CDK2SMN1; SMN2
SCHEMBL29015726 0.68 PI4KA (0.36) CDK1CCNB1CCNE1CDK2ALDH1A1
SCHEMBL2948868 0.68 CYP1A2 (0.53) CDK1CCNB1CCNE1CDK2SMN1; SMN2
SCHEMBL2946285 0.67 PDE4B (0.46) ALDH1A1SMN1; SMN2LMNA
SCHEMBL2946282 0.67 CNR1 (0.36) CDK1CCNB1CCNE1CDK2DHFR
SCHEMBL26608024 0.66 ALDH1A1 (0.50) CTSSALDH1A1SMN1; SMN2TLR7NPSR1
SCHEMBL2946551 0.66 CDK1 (0.41) CDK1CCNB1CCNE1CDK2DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010111406-A2 COMPOUNDS AND THERAPEUTIC USES THEREOF MYRIAD PHARMACEUTICALS, INC. (US) 2010-09-30 WO claimed